The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Darbepoetin Alfa Injection Market Research Report 2025

Global Darbepoetin Alfa Injection Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1629129

No of Pages : 85

Synopsis
Darbepoetin alfa (INN) is a re-engineered form of erythropoietin containing 5 amino acid changes (N30, T32, V87, N88, T90) resulting in the creation of 2 new sites for N-linked carbohydrate addition.
The global Darbepoetin Alfa Injection market was valued at US$ 715 million in 2023 and is anticipated to reach US$ 1109.3 million by 2030, witnessing a CAGR of 6.0% during the forecast period 2024-2030.
The Darbepoetin Alfa Injection market has grown as a treatment option for anemia associated with chronic kidney disease, cancer, and certain other conditions. Darbepoetin alfa is a synthetic form of erythropoietin, a hormone that stimulates red blood cell production. These injections help increase hemoglobin levels, alleviating fatigue and improving patients' quality of life. The market's expansion is driven by the need for effective anemia management in patients undergoing treatments like chemotherapy or dialysis. As medical understanding of anemia's impact on various conditions deepens, the Darbepoetin Alfa Injection market continues to provide a valuable therapeutic option to improve patients' overall well-being.
This report aims to provide a comprehensive presentation of the global market for Darbepoetin Alfa Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Darbepoetin Alfa Injection.
Report Scope
The Darbepoetin Alfa Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Darbepoetin Alfa Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Darbepoetin Alfa Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amgen
Johnson & Johnson
Kyowa Hakko Kirin
Novartis
3SBio
Segment by Type
Epogen
Procrit
Aranesp
Others
Segment by Application
Chronic Kidney Disease
Cancer
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Darbepoetin Alfa Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Darbepoetin Alfa Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Darbepoetin Alfa Injection Market Overview
1.1 Product Overview and Scope of Darbepoetin Alfa Injection
1.2 Darbepoetin Alfa Injection Segment by Type
1.2.1 Global Darbepoetin Alfa Injection Market Value Comparison by Type (2024-2030)
1.2.2 Epogen
1.2.3 Procrit
1.2.4 Aranesp
1.2.5 Others
1.3 Darbepoetin Alfa Injection Segment by Application
1.3.1 Global Darbepoetin Alfa Injection Market Value by Application: (2024-2030)
1.3.2 Chronic Kidney Disease
1.3.3 Cancer
1.3.4 Others
1.4 Global Darbepoetin Alfa Injection Market Size Estimates and Forecasts
1.4.1 Global Darbepoetin Alfa Injection Revenue 2019-2030
1.4.2 Global Darbepoetin Alfa Injection Sales 2019-2030
1.4.3 Global Darbepoetin Alfa Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Darbepoetin Alfa Injection Market Competition by Manufacturers
2.1 Global Darbepoetin Alfa Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Darbepoetin Alfa Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Darbepoetin Alfa Injection Average Price by Manufacturers (2019-2024)
2.4 Global Darbepoetin Alfa Injection Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Darbepoetin Alfa Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Darbepoetin Alfa Injection, Product Type & Application
2.7 Darbepoetin Alfa Injection Market Competitive Situation and Trends
2.7.1 Darbepoetin Alfa Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Darbepoetin Alfa Injection Players Market Share by Revenue
2.7.3 Global Darbepoetin Alfa Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Darbepoetin Alfa Injection Retrospective Market Scenario by Region
3.1 Global Darbepoetin Alfa Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Darbepoetin Alfa Injection Global Darbepoetin Alfa Injection Sales by Region: 2019-2030
3.2.1 Global Darbepoetin Alfa Injection Sales by Region: 2019-2024
3.2.2 Global Darbepoetin Alfa Injection Sales by Region: 2025-2030
3.3 Global Darbepoetin Alfa Injection Global Darbepoetin Alfa Injection Revenue by Region: 2019-2030
3.3.1 Global Darbepoetin Alfa Injection Revenue by Region: 2019-2024
3.3.2 Global Darbepoetin Alfa Injection Revenue by Region: 2025-2030
3.4 North America Darbepoetin Alfa Injection Market Facts & Figures by Country
3.4.1 North America Darbepoetin Alfa Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Darbepoetin Alfa Injection Sales by Country (2019-2030)
3.4.3 North America Darbepoetin Alfa Injection Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Darbepoetin Alfa Injection Market Facts & Figures by Country
3.5.1 Europe Darbepoetin Alfa Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Darbepoetin Alfa Injection Sales by Country (2019-2030)
3.5.3 Europe Darbepoetin Alfa Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Darbepoetin Alfa Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Darbepoetin Alfa Injection Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Darbepoetin Alfa Injection Sales by Country (2019-2030)
3.6.3 Asia Pacific Darbepoetin Alfa Injection Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Darbepoetin Alfa Injection Market Facts & Figures by Country
3.7.1 Latin America Darbepoetin Alfa Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Darbepoetin Alfa Injection Sales by Country (2019-2030)
3.7.3 Latin America Darbepoetin Alfa Injection Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Darbepoetin Alfa Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Darbepoetin Alfa Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Darbepoetin Alfa Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Darbepoetin Alfa Injection Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Darbepoetin Alfa Injection Sales by Type (2019-2030)
4.1.1 Global Darbepoetin Alfa Injection Sales by Type (2019-2024)
4.1.2 Global Darbepoetin Alfa Injection Sales by Type (2025-2030)
4.1.3 Global Darbepoetin Alfa Injection Sales Market Share by Type (2019-2030)
4.2 Global Darbepoetin Alfa Injection Revenue by Type (2019-2030)
4.2.1 Global Darbepoetin Alfa Injection Revenue by Type (2019-2024)
4.2.2 Global Darbepoetin Alfa Injection Revenue by Type (2025-2030)
4.2.3 Global Darbepoetin Alfa Injection Revenue Market Share by Type (2019-2030)
4.3 Global Darbepoetin Alfa Injection Price by Type (2019-2030)
5 Segment by Application
5.1 Global Darbepoetin Alfa Injection Sales by Application (2019-2030)
5.1.1 Global Darbepoetin Alfa Injection Sales by Application (2019-2024)
5.1.2 Global Darbepoetin Alfa Injection Sales by Application (2025-2030)
5.1.3 Global Darbepoetin Alfa Injection Sales Market Share by Application (2019-2030)
5.2 Global Darbepoetin Alfa Injection Revenue by Application (2019-2030)
5.2.1 Global Darbepoetin Alfa Injection Revenue by Application (2019-2024)
5.2.2 Global Darbepoetin Alfa Injection Revenue by Application (2025-2030)
5.2.3 Global Darbepoetin Alfa Injection Revenue Market Share by Application (2019-2030)
5.3 Global Darbepoetin Alfa Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Amgen
6.1.1 Amgen Corporation Information
6.1.2 Amgen Description and Business Overview
6.1.3 Amgen Darbepoetin Alfa Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Amgen Darbepoetin Alfa Injection Product Portfolio
6.1.5 Amgen Recent Developments/Updates
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Corporation Information
6.2.2 Johnson & Johnson Description and Business Overview
6.2.3 Johnson & Johnson Darbepoetin Alfa Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Johnson & Johnson Darbepoetin Alfa Injection Product Portfolio
6.2.5 Johnson & Johnson Recent Developments/Updates
6.3 Kyowa Hakko Kirin
6.3.1 Kyowa Hakko Kirin Corporation Information
6.3.2 Kyowa Hakko Kirin Description and Business Overview
6.3.3 Kyowa Hakko Kirin Darbepoetin Alfa Injection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Kyowa Hakko Kirin Darbepoetin Alfa Injection Product Portfolio
6.3.5 Kyowa Hakko Kirin Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Corporation Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Darbepoetin Alfa Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novartis Darbepoetin Alfa Injection Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 3SBio
6.5.1 3SBio Corporation Information
6.5.2 3SBio Description and Business Overview
6.5.3 3SBio Darbepoetin Alfa Injection Sales, Revenue and Gross Margin (2019-2024)
6.5.4 3SBio Darbepoetin Alfa Injection Product Portfolio
6.5.5 3SBio Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Darbepoetin Alfa Injection Industry Chain Analysis
7.2 Darbepoetin Alfa Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Darbepoetin Alfa Injection Production Mode & Process
7.4 Darbepoetin Alfa Injection Sales and Marketing
7.4.1 Darbepoetin Alfa Injection Sales Channels
7.4.2 Darbepoetin Alfa Injection Distributors
7.5 Darbepoetin Alfa Injection Customers
8 Darbepoetin Alfa Injection Market Dynamics
8.1 Darbepoetin Alfa Injection Industry Trends
8.2 Darbepoetin Alfa Injection Market Drivers
8.3 Darbepoetin Alfa Injection Market Challenges
8.4 Darbepoetin Alfa Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’